Safety and Efficacy of Bimatoprost Compared With Latanoprost in Patients With Glaucoma or Ocular Hypertension

Study Identifier
192024-034
CT.gov Identifier
NCT00541242
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Ocular Hypertension
  • Glaucoma - Other
    • Study Drug
  • bimatoprost 0.03% eye drops
  • latanoprost 0.005% eye drops
    • Phase
    Phase 4
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Ocular hypertension or chronic glaucoma * Patient requires IOP-lowering therapy in both eyes
    Exclusion Criteria:
    * Uncontrolled medical conditions * Hypersensitivity to study medications

    Protocol Summary

    The study will compare the safety and efficacy of Bimatoprost and Latanoprost in patients with glaucoma or ocular hypertension

    Study Locations

    Location
    Status
    Location
    Newport Beach, California, United States
    Status
    Not applicable